Novartis said it believes its new gene therapy for spinal muscular atrophy, a genetic disease affecting voluntary muscle movement, will be worth more than $4 million per dose, according to STAT. The ...
Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting specialized nerve cells that control voluntary muscle movement, according to the Muscular Dystrophy Association (MDA). It can ...
The Well News on MSN
Study looks at how warm-ups influence strength and power
WASHINGTON - Warming up before exercise is one of those steps most people know they're "supposed" to take, but don't always ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback